The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma. (Q52901931)
Jump to navigation
Jump to search
scientific article published on 24 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma. |
scientific article published on 24 August 2010 |
Statements
The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma. (English)
1 reference
1 reference
1 reference
Manfred Johannsen
1 reference
Gianluca Spitaleri
1 reference
Jan Roigas
1 reference
Steffen Weikert
1 reference
Carsten Kempkensteffen
1 reference
Andreas Roemer
1 reference
Christian Kloeters
1 reference
Patrik Rogalla
1 reference
Gabriele Pecher
1 reference
Kurt Miller
1 reference
Alexander Berndt
1 reference
Hartwig Kosmehl
1 reference
Eveline Trachsel
1 reference
Manuela Kaspar
1 reference
Valeria Lovato
1 reference
Reinerio González-Iglesias
1 reference
Leonardo Giovannoni
1 reference
Hans D Menssen
1 reference
24 August 2010
1 reference
46
1 reference
2926-2935
1 reference
16
1 reference